Analyst Consensus ?
ConsensusHold30 ratings
Bullish1860.0%
Neutral930.0%
Bearish310.0%
Sysco Corporation · SYY · FY2025 Q1 · Calendar Q4 2024
Sysco Maintains FY25 Outlook as Specialty Growth Offsets Margin Pressure
The current analysis supports a cautiously constructive operating thesis: specialty and international growth, SYGMA, total-team selling, and strategic sourcing provide avenues for continued expansion, but the case depends on improving local growth while managing margin mix and compensation-transition risks.
Reported Before market openNYSEConsumer Defensive
$40.42B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$1.09
Consensus $1.13
EPS surprise
-3.5%
Reported versus consensus
Reported revenue
$20.48B
Consensus $20.47B
Revenue surprise
+0.1%
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
-1.2%
Event window
SPY move
+0.2%
Same window
Abnormal move
-1.4%
Stock minus SPY
Volume
2.0×
Versus trailing sessions
Subsequent drift
+3.0%
Up to 20 sessions
SYYSPY benchmark
Ask FN2 about SYY FY2025 Q1
Transcript, numbers and history already loaded
Why did SYY fall 1.2% after missing EPS estimates in FY2025 Q1?What changed in SYY's guidance and outlook in FY2025 Q1?Give me the bull and bear case for SYY after FY2025 Q1 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The current analysis adds a new sales-consultant compensation model, the Mexico joint-venture divestiture, and the Campbells Prime Meat acquisition. Management also reported first-quarter margin pressure but maintained full-year guidance and expects improvement in the second half.
Guidance delta
Management maintained full-year guidance; no change was supplied in the current analysis.
Key takeaways
- First-quarter revenue grew 4.4% year over year to $20.5 billion, while adjusted EPS rose 1.9% to $1.09.
- Management reaffirmed full-year guidance and pointed to international growth, SYGMA, specialty categories, and total-team selling.
- Gross margin declined 27 basis points because of customer mix, strategic-sourcing timing, and slightly lower Sysco-brand penetration.
- Local case growth remained modest; a new incentive-oriented sales-compensation model and targeted hiring are intended to improve it.
- Sysco announced a Mexico joint-venture divestiture and acquired Campbells Prime Meat in the UK.
Management priorities
- Expand the specialty portfolio toward a $20 billion target.
- Roll out total-team selling across Broadline accounts.
- Integrate Edward Don and Campbells Prime Meat offerings.
- Add distribution-center capacity and improve strategic sourcing and inbound logistics.
- Use targeted hiring and incentive alignment to improve local case growth.
Follow SYY with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$81.64Current
$84Low
$90.3Average
$102High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 27, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Oct 15, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Sep 29, 2026 |
| UBS | Buy | Buy | Maintain | Aug 5, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Aug 5, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Aug 5, 2026 |
| Bernstein | Market Perform | Market Perform | Maintain | Apr 29, 2026 |
| Barclays | Overweight | Overweight | Maintain | Apr 29, 2026 |
| Guggenheim | Buy | Buy | Maintain | Apr 2, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Feb 19, 2026 |
| Truist Securities | Buy | Buy | Maintain | Jan 28, 2026 |
| Jefferies | Buy | Buy | Maintain | Jan 28, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jul 18, 2025 |
| BMO Capital | Outperform | Outperform | Maintain | Apr 30, 2025 |
| Deutsche Bank | Buy | Buy | Maintain | May 23, 2024 |
| Stephens & Co. | Overweight | Overweight | Maintain | Jan 31, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | May 3, 2023 |
| Argus Research | Hold | Buy | Downgrade | Feb 2, 2023 |
| Consumer Edge Research | Equal Weight | Underweight | Upgrade | Nov 4, 2020 |
| Edward Jones | Buy | Hold | Upgrade | Sep 10, 2020 |
| SVB Leerink | Outperform | Outperform | Maintain | Nov 5, 2019 |
| Bank of America | Neutral | Neutral | Maintain | Oct 2, 2019 |
| Buckingham Research | Buy | Buy | Maintain | May 7, 2019 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Nov 6, 2018 |
| Argus | Buy | Buy | Maintain | Aug 16, 2018 |
| Pivotal Research | Sell | Hold | Downgrade | Aug 10, 2018 |
| Loop Capital | Buy | Buy | Maintain | Feb 6, 2018 |
| Macquarie | Outperform | Outperform | Maintain | May 3, 2016 |
| Goldman Sachs | Sell | Sell | Maintain | May 3, 2016 |
| Cleveland Research | Neutral | Underperform | Upgrade | Mar 11, 2016 |
| Cantor Fitzgerald | Sell | Hold | Downgrade | May 3, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $81.64. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Morgan Stanley | Brian Harbour | $91 | $80.97 | +11.5% | Oct 15, 2026 |
| Guggenheim | John Heinbockel | $90 | $79.6 | +10.2% | Sep 16, 2026 |
| Piper Sandler | Analyst unavailable | $84 | $82.79 | +2.9% | Aug 5, 2026 |
| Bernstein | Analyst unavailable | $85 | $73.37 | +4.1% | Apr 29, 2026 |
| Deutsche Bank | Analyst unavailable | $84 | $73.37 | +2.9% | Apr 28, 2026 |
| Wells Fargo | Analyst unavailable | $100 | $89.28 | +22.5% | Feb 19, 2026 |
| Guggenheim | Analyst unavailable | $95 | $89.91 | +16.4% | Feb 13, 2026 |
| Guggenheim | John Heinbockel | $91 | $83.21 | +11.5% | Jan 28, 2026 |
| Jefferies | Alexander Slagle | $95 | $84.22 | +16.4% | Jan 28, 2026 |
| UBS | Mark Carden | $95 | $84.18 | +16.4% | Jan 28, 2026 |
| Bernstein | Danilo Gargiulo | $90 | $83.75 | +10.2% | Jan 28, 2026 |
| Piper Sandler | Analyst unavailable | $83 | $83.92 | +1.7% | Jan 28, 2026 |
| Barclays | Analyst unavailable | $92 | $83.92 | +12.7% | Jan 28, 2026 |
| Morgan Stanley | Analyst unavailable | $85 | $77.39 | +4.1% | Jan 20, 2026 |
| Piper Sandler | Analyst unavailable | $80 | $74.22 | -2.0% | Dec 12, 2025 |
| Barclays | Analyst unavailable | $86 | $75.89 | +5.3% | Oct 29, 2025 |
| Bernstein | Analyst unavailable | $83 | $79.16 | +1.7% | Oct 22, 2025 |
| Morgan Stanley | Analyst unavailable | $88 | $79.9 | +7.8% | Oct 21, 2025 |
| Guggenheim | Analyst unavailable | $89 | $82.15 | +9.0% | Oct 6, 2025 |
| UBS | Analyst unavailable | $90 | $80.11 | +10.2% | Jul 30, 2025 |
| Wells Fargo | Analyst unavailable | $88 | $78.38 | +7.8% | Jul 29, 2025 |
| Bernstein | Jeffrey Bernstein | $87 | $73.29 | +6.6% | Apr 22, 2025 |
| Melius Research | Jacob Aiken-Phillips | $85 | $77.08 | +4.1% | Dec 18, 2024 |
| Jefferies | Alexander Slagle | $92 | $76.28 | +12.7% | Sep 25, 2024 |
| Bernstein | Jeffrey Bernstein | $88 | $76.44 | +7.8% | Jul 31, 2024 |
| Truist Financial | Jake Bartlett | $85 | $73.29 | +4.1% | Jun 24, 2024 |
| Guggenheim | John Heinbockel | $85 | $72.95 | +4.1% | May 28, 2024 |
| Deutsche Bank | Lauren Silberman | $86 | $73.1 | +5.3% | May 23, 2024 |
| Morgan Stanley | Brian Harbour | $82 | $72.73 | +0.4% | May 23, 2024 |
| BMO Capital | Kelly Bania | $85 | $72.92 | +4.1% | May 23, 2024 |
| UBS | Mark Carden | $87 | $72.73 | +6.6% | May 23, 2024 |
| Barclays | Jeffrey Bernstein | $85 | $72.73 | +4.1% | May 23, 2024 |
| Barclays | Jeffrey Bernstein | $88 | $74.32 | +7.8% | May 1, 2024 |
| Truist Financial | Jake Bartlett | $87 | $66.44 | +6.6% | Sep 29, 2023 |
| Wells Fargo | Analyst unavailable | $85 | $76.96 | +4.1% | Feb 6, 2023 |
| Morgan Stanley | Analyst unavailable | $86 | $76.96 | +5.3% | Feb 1, 2023 |
| Barclays | Analyst unavailable | $87 | $77.46 | +6.6% | Feb 1, 2023 |
| Credit Suisse | Analyst unavailable | $94 | $77.46 | +15.1% | Feb 1, 2023 |
| Deutsche Bank | Analyst unavailable | $80 | $77.46 | -2.0% | Feb 1, 2023 |
| Wells Fargo | Analyst unavailable | $87 | $75.73 | +6.6% | Jan 4, 2023 |
| CFRA | Paul Silverstein | $102 | $86.05 | +24.9% | May 11, 2022 |
| Morgan Stanley | Analyst unavailable | $94 | $85.21 | +15.1% | May 11, 2022 |
| Barclays | Analyst unavailable | $100 | $88.8 | +22.5% | Apr 25, 2022 |
| Bernstein | Jeffrey Bernstein | $100 | $88.8 | +22.5% | Apr 25, 2022 |
| Argus Research | John Staszak | $95 | $84.24 | +16.4% | Feb 22, 2022 |
| Truist Financial | Jake Bartlett | $89 | $77.71 | +9.0% | Jan 31, 2022 |
| UBS | Mark Carden | $93 | $76.81 | +13.9% | Aug 11, 2021 |
| Credit Suisse | Lauren Silberman | $97 | $81.12 | +18.8% | May 5, 2021 |
Track every rating change on SYY the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationSysco Corporation, through its subsidiaries, engages in the marketing and distribution of various food and related products to the foodservice or food-away-from-home industry in the United States, Canada, the United Kingdom, France, and internationally. It operates through U.S. Foodservice Operations, International Foodservice Operations, SYGMA, and Other segments. The company distributes frozen food, such as meat, seafood, fully prepared entrées, fruits, vegetables, and desserts; canned and dry food products; fresh meat and seafood products; dairy products; beverages; imported specialties…
Historical context
All SYY earningsConsumer Defensive peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| KOF Coca-Cola FEMSA, S.A.B. de C.V. | FY2026 Q3 · Calendar Q4 2026 | -9.0% | -1.9% | KOF: Record volume growth meets cost and capacity pressure |
| PG The Procter & Gamble Company | FY2027 Q1 · Calendar Q4 2026 | +6.4% | +5.6% | P&G: Volume Growth Supports FY2027 Guidance Despite Cost Headwinds |
Latest beats and misses
Who reports nextBeat on EPS
- VZFY2026 Q3 · October 26, 2026+3.1% EPS-3.5% move
- CXFY2026 Q3 · October 26, 2026+12.0% EPS-0.1% move
- CDNSFY2026 Q3 · October 26, 2026+2.9% EPS+1.8% move
- BAHFY2027 Q2 · October 23, 2026+18.9% EPS-0.3% move
- FCNCAFY2026 Q3 · October 23, 2026+19.9% EPS+8.2% move
- FCNCNFY2026 Q3 · October 23, 2026+19.9% EPS+0.2% move
Missed on EPS
- KOFFY2026 Q3 · October 26, 2026-9.0% EPS-1.9% move
- INFYFY2027 Q2 · October 23, 2026-4.8% EPS-6.6% move
- BBDFY2026 Q3 · October 22, 2026-7.7% EPS+3.0% move
- SNAFY2026 Q3 · October 22, 2026-5.9% EPS-3.4% move
- SPOTFY2026 Q3 · October 22, 2026-11.6% EPS+11.1% move
- VRSNFY2026 Q3 · October 22, 2026-2.0% EPS-0.9% move
Get the SYY recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2024-11-10T18:38:36.707185+00:00
- Polygon adjusted daily market bars · 2026-10-27T12:50:42.384472+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-27T12:50:42.380723+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-27. For educational purposes only; not investment advice.